Q: Current thoughts on this one after the quarter?
Thx
Thx
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi team ,
Why is Well crashing today??
Thanks
Shane
Why is Well crashing today??
Thanks
Shane
Q: can you give me an update on how you think this microcap is doing
Q: metallurgical coal. What Canadian public companies earn significant revenues from it?Aside from Teck.
Q: Did you attend the conference call? Thoughts on the report?
Q: Good afternoon!
I would appreciate an update on your views about the residential arm of Dream. They seem to be doing well, but I was hoping you might help me spot any red flags here, or point out where I am not seeing the data correctly. My cursory review noted the following:
1) Debt to assets only 31.9%
2) Stock price at 50% NAV
3) Paid $10.5 distributions, out of $.18 FFO, which implies a payout ratio of only 58%, which seems low and I would think adds to some margin of safety for a small firm.
4) Actually are buying back stock, although minimally.
5) Dividend seems very good at almost 7%.
Thanks!
Paul
I would appreciate an update on your views about the residential arm of Dream. They seem to be doing well, but I was hoping you might help me spot any red flags here, or point out where I am not seeing the data correctly. My cursory review noted the following:
1) Debt to assets only 31.9%
2) Stock price at 50% NAV
3) Paid $10.5 distributions, out of $.18 FFO, which implies a payout ratio of only 58%, which seems low and I would think adds to some margin of safety for a small firm.
4) Actually are buying back stock, although minimally.
5) Dividend seems very good at almost 7%.
Thanks!
Paul
Q: When a stock trades at a ratio of revenue to enterprise value of less than one, does it imply great value especially if the revenues are mostly recurring? It seems like a lot of small cap tech names are in that category.
Q: What did you think of LTRX's recent quarterly results and guidance?
Q: Based on the latest quarter and estimates STC has now low debt leverage (2X TMT EBITDA) and high free cash flow yields (17%). Is this not a good sign of financial health?
Q: How is Tantalus Systems coming along, I've owned it and been interested in it for a while. What do you think or their recent earnings and can I still hold it for a long term hold? Thanks.
-
Sylogist Ltd. (SYZ)
-
Celestica Inc. (CLS)
-
Kinaxis Inc. (KXS)
-
TECSYS Inc. (TCS)
-
Converge Technology Solutions Corp. (CTS)
-
Docebo Inc. (DCBO)
Q: I'm late to the party with TCS, CTS and SYZ. I don't own any of them and wonder if they still have "legs" or have they had their runs. Looking for other small Canadian Tech you find interesting.
Q: Pain in a TFSA. Invested $6,200 into Sangoma and it's now $800. Invested $15,000 into Converge and it's now $5,000.
I don't mind waiting, but will these ever recover?
I don't mind waiting, but will these ever recover?
Q: Based on your previous comments on Pliant Therapeutics could you please give an opinion on recent earnings and going forward what do you see for the stock and the market they are in. Can you also comment on management and insider ownership if they are worthy enough points to even discuss.
Thank you.
Thank you.
Q: Is PBL a buy at this time, well of its highs, but PE seems high. Would it be somewhat recession proof. Thanks for your analysis.
Q: Hello 5i Team,
Can I please get your current opinion on Profound Medical? Do you see it as a buy, given the risk level? The recent earnings call sounded very optimistic with a deal signed to install their prostate cancer/BPH thermal ultrasound treatment in 20 Cleveland Clinics across North America. They also mentioned a code approval in the US effective January 2025. Thanks. Brad
Can I please get your current opinion on Profound Medical? Do you see it as a buy, given the risk level? The recent earnings call sounded very optimistic with a deal signed to install their prostate cancer/BPH thermal ultrasound treatment in 20 Cleveland Clinics across North America. They also mentioned a code approval in the US effective January 2025. Thanks. Brad
Q: Your comments on 3rd quarter results please.
Q: What is your outlook for Illumin going forward, what do you think of the recent earnings. I seem to remember that you guys liked this stock before but if and when things pick up for this company will you guys like it for all the same reasons. How do they stack up against competition in the same market?Can you comment on insider ownership, any notable financial ratios (good or bad) and the overall management please. Thank you.
Q: What did you think of the recent earnings and CEO's outlook?
TIA
TIA
Q: I am down considerably on SXP. Is it a hold or sell?
Q: Is the high debt load consuming this company's cash? What is the cash burn rate as you see it and what are the payments on the debt currently? Thanks.